You have 9 free searches left this month | for more free features.
Clincosm LogoSign in Get a demo

adult nodular sclerosis Hodgkin lymphoma

Showing 1 - 25 of >10,000
STUDY
CONDITIONS
INTERVENTIONS
LOCATIONS
LAST UPDATED

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Completed
Has Results
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +5 more
  • gemcitabine hydrochloride
  • bendamustine hydrochloride
  • Atlanta, Georgia
  • +1 more
Oct 21, 2021

Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

Active, not recruiting
  • Adult Lymphocyte Depletion Hodgkin Lymphoma
  • +16 more
  • 6,8-bis(benzylthio)octanoic acid
  • bendamustine hydrochloride
  • Winston-Salem, North Carolina
  • +1 more
Apr 8, 2022

Quality of Life in Adult and Pediatric Nodular

Recruiting
  • Nodular Lymphocyte-Predominant Hodgkin Lymphoma
    • Aurora, Colorado
    • +1 more
    Oct 27, 2023

    Nodular Lymphocyte Predominant Hodgkin Lymphoma, Recurrent Nodular Lymphocyte Predominant Hodgkin Lymphoma, Refractory Nodular

    Not yet recruiting
    • Nodular Lymphocyte Predominant Hodgkin Lymphoma
    • +2 more
    • Biopsy
    • +9 more
    • (no location specified)
    Jun 1, 2023

    Social and Genetic Factors on Outcomes in Adolescent and Young

    Not yet recruiting
    • Hodgkin Lymphoma
    • Non-Hodgkin Lymphoma
    • Biospecimen Collection
    • +2 more
    • (no location specified)
    Aug 18, 2023

    Relapsed or Refractory Non-Hodgkin's Lymphoma Trial in China (AXT-1003)

    Not yet recruiting
    • Relapsed or Refractory Non-Hodgkin's Lymphoma
    • Beijing, China
    • +3 more
    Jul 20, 2023

    Hodgkin Lymphoma, Stage I Adult Hodgkin Lymphoma, Stage II Adult Hodgkin Lymphoma Trial in Rochester (drug, genetic, other)

    Withdrawn
    • Hodgkin Lymphoma
    • +4 more
    • Rochester, Minnesota
      Mayo Clinic
    Nov 28, 2022

    Relapsed or Refractory B Cell Non-Hodgkin Lymphoma Trial (C-CAR066)

    Not yet recruiting
    • Relapsed or Refractory B Cell Non-Hodgkin Lymphoma
    • (no location specified)
    Mar 23, 2023

    Immunogenicity of COVID-19 Vaccinations in Autologous HSCT

    Not yet recruiting
    • COVID-19
    • +2 more
      • Cologne, NRW, Germany
        University Hospital of Cologne
      Oct 27, 2022

      Mature B-Cell Non-Hodgkin Lymphoma Trial (Obinutuzumab, Glofitamab, Rituximab)

      Not yet recruiting
      • Mature B-Cell Non-Hodgkin Lymphoma
      • (no location specified)
      Sep 6, 2022

      Advanced or Metastatic Solid Tumors, Non-Hodgkin Lymphoma Trial in San Antonio (WTX-330)

      Recruiting
      • Advanced or Metastatic Solid Tumors
      • Non-Hodgkin Lymphoma
      • San Antonio, Texas
        NEXT Oncology
      Jan 6, 2023

      B-cell Non Hodgkin Lymphoma, Chronic Lymphocytic Leukemia Trial in Charleston (Cyclophosphamide injection, Fludarabine

      Not yet recruiting
      • B-cell Non Hodgkin Lymphoma
      • Chronic Lymphocytic Leukemia
      • Cyclophosphamide injection
      • +2 more
      • Charleston, South Carolina
        Hollings Cancer Center at Medical University of South Carolina
      Jan 18, 2023

      NHL, NHL, Relapsed, Adult Trial in United States (CLN-978)

      Recruiting
      • NHL
      • NHL, Relapsed, Adult
      • Birmingham, Alabama
      • +4 more
      May 31, 2023

      Lymphoma, Non-Hodgkin's, Adult Trial (SP-3164)

      Not yet recruiting
      • Lymphoma, Non-Hodgkin's, Adult
      • (no location specified)
      Aug 4, 2023

      Non-hodgkin Lymphoma, Acute Lymphoblastic Leukaemia, Chronic Lymphocytic Leukemia Trial in Tianjin (CC312)

      Recruiting
      • Non-hodgkin Lymphoma
      • +2 more
      • CC312
      • Tianjin, Tianjin, China
        InstituteHBDH
      Sep 12, 2023

      Non Hodgkin Lymphoma Trial in Aurora (UCD19 CAR T Cells)

      Active, not recruiting
      • Non Hodgkin Lymphoma
      • UCD19 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      Hodgkin Lymphoma, Refractory Hodgkin Lymphoma, Relapsed Hodgkin's Disease, Adult Trial in Leon (Brentuximab Vedotin 50 MG

      Recruiting
      • Hodgkin Lymphoma
      • +2 more
      • Brentuximab Vedotin 50 MG [Adcetris]
      • Leon, Guanajuato, Mexico
        Hospital Regional Alta Especialidad Bajio
      Oct 24, 2022

      B Cell Non-Hodgkin's Lymphoma Trial in Duarte (CD19/CD20-directed CAR-T cells)

      Recruiting
      • B Cell Non-Hodgkin's Lymphoma
      • CD19/CD20-directed CAR-T cells
      • Duarte, California
        City of Hope Medical Center
      Aug 10, 2022

      Adult Lymphocyte Depletion Hodgkin Lymphoma, Adult Lymphocyte Predominant Hodgkin Lymphoma, Adult Mixed Cellularity Hodgkin

      Unknown status
      • Adult Lymphocyte Depletion Hodgkin Lymphoma
      • +6 more
      • brentuximab vedotin
      • +11 more
      • Stanford, California
      • +6 more
      Feb 14, 2020

      B-cell Lymphoma, Non Hodgkin Lymphoma, DLBCL Trial in Louisville (Cyclophosphamide, Fludarabine, ACE1831)

      Recruiting
      • B-cell Lymphoma
      • +5 more
      • Louisville, Kentucky
        Norton Cancer Institute
      Jan 24, 2023

      Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma, Ann Arbor Stage I Grade 1 Follicular Lymphoma, Ann Arbor Stage I Grade 2

      Active, not recruiting
      • Ann Arbor Stage I B-Cell Non-Hodgkin Lymphoma
      • +22 more
      • External Beam Radiation Therapy
      • Orbital Radiation
      • Houston, Texas
        M D Anderson Cancer Center
      Dec 9, 2022

      Non-Hodgkin Lymphoma Trial in Aurora (CD19x22 CAR T Cells)

      Active, not recruiting
      • Non-Hodgkin Lymphoma
      • CD19x22 CAR T Cells
      • Aurora, Colorado
        University of Colorado Hospital
      Sep 1, 2022

      Multiple Myeloma, Non-Hodgkin Lymphoma, Diffuse Large B Cell Lymphoma Trial in Minneapolis (Nicotinamide Expanded Haploidentical

      Completed
      • Multiple Myeloma
      • +7 more
      • Nicotinamide Expanded Haploidentical or Mismatched Related Donor Natural Killer Cells
      • Minneapolis, Minnesota
        Masonic Cancer Center, University of Minnesota
      Nov 2, 2022

      Adult Grade III Lymphomatoid Granulomatosis, Cutaneous B-cell Non-Hodgkin Lymphoma, MALT Trial in Duarte (biological, procedure,

      Active, not recruiting
      • Adult Grade III Lymphomatoid Granulomatosis
      • +23 more
      • autologous CD19CAR-CD28-CD3zeta-EGFRt-expressing Tcm-enriched T cells
      • +2 more
      • Duarte, California
        City of Hope Medical Center
      Jan 4, 2023

      Follicular Lymphoma, Low Grade Non-Hodgkin's Lymphoma, Adult Trial in Boston (Epcoritamab, Rituximab)

      Not yet recruiting
      • Follicular Lymphoma
      • Low Grade Non-Hodgkin's Lymphoma, Adult
      • Boston, Massachusetts
        Dana-Farber Cancer Institute
      Mar 13, 2023